Thomas Reiser Invites You to Join the ISTH Academy Industry Portal: Be at the Forefront
Thomas Reiser, Executive Director of International Society on Thrombosis and Haemostasis (ISTH), shared an invitation, reposting from ISTH on X:
”Part of the world-class content on the ISTH Academy are educational disease-state, lab diagnostic and clinical care education materials developed and provided by our industry partners.
Take advantage of these additional resources and stay up to date with the latest developments in T and H!
ISTH on X:
‘ISTH members: Have you explored the Industry Portal on the ISTH Academy? Get exclusive access to expert-driven resources on the latest therapies in hemophilia and coagulation disorder care designed to keep you at the forefront.’
Explore the content.
Stay updated on all opportunities in the field of bleeding disorders and thrombosis with Hemostasis Today.
-
Aug 4, 2025, 17:06Nathan Connell and John Fanikos Invite You to the Vasculearn Network Podcast
-
Aug 4, 2025, 16:44Honoring Visionary Leadership in Hemophilia Care: A Tribute to Drs. Cesar Garrido and Assad Haffar
-
Aug 4, 2025, 14:54Shreyas Kalantri: Engaging Insights on VTE Management
-
Aug 4, 2025, 06:00Genotype–Phenotype Understanding in Hemophilia B: Commentary on Factor IX Missense Variants
-
Aug 4, 2025, 05:47National Health Center Week – Recognizing the Vital Role of HTCs in Specialized Care
-
Aug 4, 2025, 17:29MADD: First Causal Gene for Quantitative Von Willebrand Disease Discovered
-
Aug 4, 2025, 16:13Nicolas Gendron on TITAN’s Recent Study: Insights on Managing Pregnancy in Antithrombin Deficiency
-
Aug 4, 2025, 01:59Michael Makris Posts Haemophilia Journal Article Reassessing UK Blood Inquiry
-
Aug 4, 2025, 01:09Manuel Monreal Congratulates Authors Ahead of JTH Publication: VTE-Predict Score Validated in RIETE Cohort
-
Aug 3, 2025, 17:48Nathan Connell: What Is The "Mild Equivalent" For Hemophilia A That Is Achieved While on Emicizumab?
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Aug 4, 2025, 05:20NBCA: Alexis’s DVT Diagnosis Came Without Warning - Learn How She Caught It Early
-
Aug 4, 2025, 00:50NBCA: After Losing Her Daughter to a Blood Clot, Charita Fights to Save Others
-
Aug 3, 2025, 18:10Andrew Agwunobi Congrats Dr. Oladipo Cole and The Whole Team at the Connecticut Bleeding Disorder Center
-
Aug 3, 2025, 12:03Elias Bouchi Presents Werfen EEMEA Talks on Hemostasis: Clot Stories Season 3
-
Jul 31, 2025, 15:37Sano Genetics: “Unreasonable” Leadership with Benny Sorenson of Hemab